Perceived Burdens Predict Patients’ Withdrawal From Cancer Trials
Cancer patients are more likely to withdraw from clinical trials if the perceived burdens of participation outweigh the perceived benefits.
Cancer patients are more likely to withdraw from clinical trials if the perceived burdens of participation outweigh the perceived benefits.
Previous studies have shown that dasatinib may be an effective therapeutic alternative to imatinib.